Form 8-K - Current report:
SEC Accession No. 0000939767-21-000096
Filing Date
2021-11-02
Accepted
2021-11-02 16:11:33
Documents
15
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exel-20211102.htm   iXBRL 8-K 37573
2 EX-99.1 exel20210930exhibit991.htm EX-99.1 153223
6 GRAPHIC exel-20211102_g1.jpg GRAPHIC 116418
7 GRAPHIC exellogo18q3a20.jpg GRAPHIC 116418
  Complete submission text file 0000939767-21-000096.txt   762212

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20211102.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20211102_lab.xml EX-101.LAB 24137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20211102_pre.xml EX-101.PRE 12520
8 EXTRACTED XBRL INSTANCE DOCUMENT exel-20211102_htm.xml XML 10637
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30235 | Film No.: 211371436
SIC: 2836 Biological Products, (No Diagnostic Substances)